Intravitreal Aflibercept for the Prevention of Proliferative Vitreoretinopathy Following Retinal Detachment Repair

Clinical trial NCT04580147 · UNKNOWN

Trial details

NCT number: NCT04580147
Sponsor: M. Ali Khan, MD
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Retinal Detachment With Multiple Breaks, Unspecified Eye Proliferative Vitreoretinopathy

Start date: 2020-10-15
Primary completion: 2023-09-15
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.